These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 19652523)

  • 21. Vancomycin MIC creep in non-vancomycin-intermediate Staphylococcus aureus (VISA), vancomycin-susceptible clinical methicillin-resistant S. aureus (MRSA) blood isolates from 2001-05.
    Steinkraus G; White R; Friedrich L
    J Antimicrob Chemother; 2007 Oct; 60(4):788-94. PubMed ID: 17623693
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Linezolid and quinupristin/dalfopristin resistance in vancomycin-resistant enterococci and methicillin-resistant Staphylococcus aureus prior to clinical use in Turkey.
    Baysallar M; Kilic A; Aydogan H; Cilli F; Doganci L
    Int J Antimicrob Agents; 2004 May; 23(5):510-2. PubMed ID: 15120733
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activity of AZD2563, a novel oxazolidinone, against Staphylococcus aureus strains with reduced susceptibility to vancomycin or linezolid.
    Howe RA; Wootton M; Noel AR; Bowker KE; Walsh TR; MacGowan AP
    Antimicrob Agents Chemother; 2003 Nov; 47(11):3651-2. PubMed ID: 14576139
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [In vitro activity of linezolid/ertapenem combination in resistant gram-positive bacteria].
    Eraç B; Taşli H; Ermertcan S; Cilli F; Limoncu MH
    Mikrobiyol Bul; 2009 Jan; 43(1):45-51. PubMed ID: 19334379
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Report-Isolation identification and control of vancomycin resistant Staphylococcus aureus.
    Liaqat F; Sheikh AA; Nazir J; Hussain T; Rabbani M; Shaheen AY; Muhammad J
    Pak J Pharm Sci; 2015 May; 28(3):997-1004. PubMed ID: 26004734
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Resistance selection studies comparing the activity of razupenem (PTZ601) to vancomycin and linezolid against eight methicillin-resistant and two methicillin-susceptible Staphylococcus aureus strains.
    Clark C; Kosowska-Shick K; McGhee P; Dewasse B; Beachel L; Appelbaum PC
    Antimicrob Agents Chemother; 2009 Jul; 53(7):3118-21. PubMed ID: 19433566
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activity of ceftaroline against extracellular (broth) and intracellular (THP-1 monocytes) forms of methicillin-resistant Staphylococcus aureus: comparison with vancomycin, linezolid and daptomycin.
    Mélard A; Garcia LG; Das D; Rozenberg R; Tulkens PM; Van Bambeke F; Lemaire S
    J Antimicrob Chemother; 2013 Mar; 68(3):648-58. PubMed ID: 23188792
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative in vitro activity of telavancin, vancomycin and linezolid against heterogeneously vancomycin-intermediate Staphylococcus aureus (hVISA).
    Leonard SN; Szeto YG; Zolotarev M; Grigoryan IV
    Int J Antimicrob Agents; 2011 Jun; 37(6):558-61. PubMed ID: 21497067
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro activity of retapamulin against linezolid and methicillin-resistant Staphylococcus aureus isolates.
    Candel FJ; Morales G; Picazo JJ
    Rev Esp Quimioter; 2011 Sep; 24(3):127-30. PubMed ID: 21947094
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro 24-hour time-kill studies of vancomycin and linezolid in combination versus methicillin-resistant Staphylococcus aureus.
    Singh SR; Bacon AE; Young DC; Couch KA
    Antimicrob Agents Chemother; 2009 Oct; 53(10):4495-7. PubMed ID: 19635959
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Linezolid versus vancomycin for nosocomial pneumonia due to methicillin-resistant Staphylococcus aureus in the elderly: A retrospective cohort analysis: Effectiveness of linezolid in the elderly.
    Takada H; Hifumi T; Nishimoto N; Kanemura T; Yoshioka H; Okada I; Kiriu N; Inoue J; Koido Y; Kato H
    Am J Emerg Med; 2017 Feb; 35(2):245-248. PubMed ID: 27832976
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Linezolid tissue penetration and serum activity against strains of methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibility in diabetic patients with foot infections.
    Stein GE; Schooley S; Peloquin CA; Missavage A; Havlichek DH
    J Antimicrob Chemother; 2007 Oct; 60(4):819-23. PubMed ID: 17673476
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro activity of linezolid, quinupristin-dalfopristin, vancomycin, teicoplanin, moxifloxacin and mupirocin against methicillin-resistant Staphylococcus aureus: comparative evaluation by the E test and a broth microdilution method.
    Abb J
    Diagn Microbiol Infect Dis; 2002 Aug; 43(4):319-21. PubMed ID: 12151194
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular characterization and antibiotic resistance of clinical isolates of methicillin-resistant Staphylococcus aureus obtained from Southeast of Iran (Kerman).
    Sadeghi J; Mansouri S
    APMIS; 2014 May; 122(5):405-11. PubMed ID: 24033803
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacodynamics of early, high-dose linezolid against vancomycin-resistant enterococci with elevated MICs and pre-existing genetic mutations.
    Tsuji BT; Bulitta JB; Brown T; Forrest A; Kelchlin PA; Holden PN; Peloquin CA; Skerlos L; Hanna D
    J Antimicrob Chemother; 2012 Sep; 67(9):2182-90. PubMed ID: 22685161
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Influence of inoculum size on MICs for methicillin-susceptible Staphylococcus aureus and methicillin-resistant Staphylococcus aureus].
    Miyake N; Kadowaki M; Sato Y; Eriguchi Y; Nagasaki Y; Harada Y; Uchida Y; Shimono N
    Jpn J Antibiot; 2011 Aug; 64(4):231-7. PubMed ID: 22066347
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Linezolid resistance in a clinical isolate of Staphylococcus aureus.
    Tsiodras S; Gold HS; Sakoulas G; Eliopoulos GM; Wennersten C; Venkataraman L; Moellering RC; Ferraro MJ
    Lancet; 2001 Jul; 358(9277):207-8. PubMed ID: 11476839
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The safety and efficacy of linezolid and daptomycin as an additive in Optisol-GS against methicillin-resistant Staphylococcus aureus.
    Li J; Feiz V; Vieira AC; Davis-Boozer D; Polage C
    Cornea; 2012 May; 31(5):551-8. PubMed ID: 22378113
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Linezolid minimum inhibitory concentration (MIC) creep in methicillin-resistant Staphylococcus aureus (MRSA) clinical isolates at a single Japanese center.
    Miyazaki M; Nagata N; Miyazaki H; Matsuo K; Takata T; Tanihara S; Kamimura H
    Biol Pharm Bull; 2014; 37(4):679-82. PubMed ID: 24694615
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Staphylococcus aureus biofilm as a target for single or repeated doses of oxacillin, vancomycin, linezolid and/or lysostaphin.
    Walencka E; Sadowska B; Rózalska S; Hryniewicz W; Rózalska B
    Folia Microbiol (Praha); 2006; 51(5):381-6. PubMed ID: 17176756
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.